If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Some 20 travel staff at the FDA, who made arrangements for the regulator’s inspectors, will be getting their jobs back, as ...

Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...

Too easily overlooked are non-influenza, non-COVID viruses and bacteria that are burgeoning and spreading unchecked — both in ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Key Takeaways All new vaccines may soon require placebo testing before approvalMedical experts worry this could limit access ...

Streptococcus Group A affects close to 20% of U.S. children, according to Dr. Joshua Osowicki, senior research fellow at the ...

More than 880 measles cases have been reported in the U.S. since February, including at least 660 in Texas, amid rising ...